COMPANY:

Sectra

"Owkin...announced an integration with international medical imaging IT and cybersecurity company Sectra...to integrate Owkin’s MSIntuit® CRC AI diagnostic into Sectra’s digital pathology solution. MSIntuit® CRC is the first CE-marked AI diagnostic for microsatellite instability (MSI) testing for colorectal cancer using digital H&E slides. It serves as a pre-screening tool for colorectal cancer patients that aims to streamline MSI testing, saving critical pathology resources by significantly reducing the proportion of patients that need to be fully screened by traditional methods."

"Sectra...announces that the US health and academic center Michigan Medicine is expanding its usage of Sectra's enterprise imaging solution by including Sectra's module for digital pathology. This will enable their pathologists to review and collaborate around cases, ultimately improving cancer diagnostics in the region."

"International medical imaging IT and cybersecurity company Sectra's (STO: SECT B) solution for digital pathology will be utilized by Israel's largest healthcare provider—Clalit Health Services. The solution was sold through Sectra's distribution partner in Israel, VaRay Oncology Systems."

"International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has expanded its current contract with the South-Eastern Norway Regional Health Authority—Helse Sør-Øst RHF (HSØ). HSØ will add Sectra’s digital pathology module to the Sectra Enterprise Imaging Solution. This will enable pathology labs in the region to share resources, expertise, and workloads, thus ensuring high-quality cancer care for patients."